AGILE MEDICINE Trademark

Trademark Overview

On Monday, December 23, 2019, a trademark application was filed for AGILE MEDICINE with the United States Patent and Trademark Office. The USPTO has given the AGILE MEDICINE trademark a serial number of 79279572. The federal status of this trademark filing is REGISTERED as of Tuesday, May 18, 2021. This trademark is owned by Debiopharm International SA. The AGILE MEDICINE trademark is filed in the Insurance & Financial Services category with the following description:

Financial affairs and monetary affairs, namely, financial information, management and analysis services; financial investment advisory services
agile medicine

General Information

Serial Number79279572
Word MarkAGILE MEDICINE
Filing DateMonday, December 23, 2019
Status700 - REGISTERED
Status DateTuesday, May 18, 2021
Registration Number6350547
Registration DateTuesday, May 18, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 2, 2021

Trademark Statements

Goods and ServicesFinancial affairs and monetary affairs, namely, financial information, management and analysis services; financial investment advisory services

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, March 2, 2020
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDebiopharm International SA
Party Type30 - Original Registrant
Legal Entity Type33 - NOT AVAILABLE
AddressLausanne CH-1006
CH
Party NameDebiopharm International SA
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressLausanne CH-1006
CH
Party NameDebiopharm International SA
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressLausanne CH-1006
CH

Trademark Events

Event DateEvent Description
Monday, September 20, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, August 30, 2021FINAL DISPOSITION NOTICE SENT TO IB
Monday, August 30, 2021FINAL DISPOSITION PROCESSED
Wednesday, August 18, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 18, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, March 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 2, 2021PUBLISHED FOR OPPOSITION
Monday, March 1, 2021NOTIFICATION PROCESSED BY IB
Wednesday, February 10, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 10, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 28, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 28, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 28, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 25, 2021ASSIGNED TO LIE
Wednesday, October 14, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 1, 2020REFUSAL PROCESSED BY IB
Tuesday, April 14, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, April 14, 2020REFUSAL PROCESSED BY MPU
Friday, March 27, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, March 26, 2020NON-FINAL ACTION WRITTEN
Thursday, March 19, 2020ASSIGNED TO EXAMINER
Friday, March 6, 2020APPLICATION FILING RECEIPT MAILED
Monday, March 2, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 27, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

medicine agile financial services affairs advisory analysis investment information monetary namely management